Notice Number: NOT-HL-14-226
Key Dates
Release Date:
June 6, 2014
PAR-14-245
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
On June 4, 2014, the NHLBI issued Funding Opportunity Announcement (FOA) PAR-14-245 "Translational Programs in Lung Diseases (P01)." This Notice provides details for applicants regarding additional information on eligibility and on review criteria.
The following sections of the FOA are revised accordingly:
Part 2. Full Text of Announcement
Section III. Eligibility Information
3. Additional Information on Eligibility
Current Language:
Renewals or new applications applying directly for the second cycle: At least 50% of the program project must be clinical research unless requesting a specific exception for preclinical development activities. Cycle II applicants, see Section I for requesting an exception.
Revised Language:
Renewals or new applications applying directly for the second cycle: At least 50% of the program project must be clinical research unless requesting a specific exception for preclinical development activities. Cycle II applicants, see Section IV.2 for requesting an exception.Inquiries
Please direct all inquiries to:
Patricia Noel, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0202
Email: [email protected]
and Human Services (HHS)
